CX3CR1 and Hepatic fibrosis: These findings provide new insights into the role of splenic CX3CR1+ subset cells in fibrotic progression through the spleen-liver axis, and are valuable for developing a CX3CR1+ subset cells-targeted therapy for liver fibrosis.